Roy Nofech‐Mozes
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
-
- Renal cell carcinoma treatment
- Ferroptosis and cancer prognosis
Papers in
-
- Renal cell carcinoma treatment 4
- Ferroptosis and cancer prognosis 2
-
- Cancer Genomics and Diagnostics 2
- Co-authors
- George Makram Yousef (7 shared papers)Henriett Butz (5 shared papers)Heba W. Z. Khella (4 shared papers)Péter Márton Szabó (3 shared papers)Attila Patócs (2 shared papers)Sergey N. Krylov (3 shared papers)Qiang Ding (3 shared papers)Antonio Finelli (2 shared papers)
- Journals
- Oncotarget (2 papers)The FASEB Journal (1 paper)Cancer Medicine (1 paper)Toxicology (1 paper)Journal of Clinical Pathology (1 paper)
- Partner nations
- CanadaUnited StatesHungary
In The Last Decade
Roy Nofech‐Mozes
8 papers receiving 372 citations
Peers
Comparison fields: 5 of 52
- Cancer Research 201
- Pulmonary and Respiratory Medicine 112
- Molecular Biology 249
- Oncology 32
- Nephrology 7
Countries citing papers authored by Roy Nofech‐Mozes
This map shows the geographic impact of Roy Nofech‐Mozes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy Nofech‐Mozes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy Nofech‐Mozes more than expected).
Fields of papers citing papers by Roy Nofech‐Mozes
This network shows the impact of papers produced by Roy Nofech‐Mozes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy Nofech‐Mozes. The network helps show where Roy Nofech‐Mozes may publish in the future.
Co-authors
The 25 scholars most cited alongside Roy Nofech‐Mozes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 115 | |
| 2 | 2015 | 71 | |
| 3 | 2014 | 51 | |
| 4 | 2016 | 41 | |
| 5 | 2017 | 33 | |
| 6 | 2014 | 28 | |
| 7 | 2017 | 28 | |
| 8 | 2018 | 6 |
About Roy Nofech‐Mozes
Roy Nofech‐Mozes is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology, Nutrition and Dietetics and Pharmacology, having authored 8 papers that have together received 373 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (4 papers), Renal and related cancers (4 papers), Ferroptosis and cancer prognosis (2 papers), Cancer Genomics and Diagnostics (2 papers), Cannabis and Cannabinoid Research (1 paper), Pancreatic function and diabetes (1 paper) and Biochemical Analysis and Sensing Techniques (1 paper). The work is most often cited by research in Cancer Research (201 citations), Pulmonary and Respiratory Medicine (112 citations), Molecular Biology (249 citations), Oncology (32 citations) and Nephrology (7 citations). Roy Nofech‐Mozes has collaborated with scholars based in Canada, United States and Hungary. Frequent co-authors include George Makram Yousef, Henriett Butz, Heba W. Z. Khella, Péter Márton Szabó, Attila Patócs, Sergey N. Krylov, Qiang Ding, Antonio Finelli, Jason Kai Wei Lee and Michael H. Ordon. Their work appears in journals such as Oncotarget, The FASEB Journal, Cancer Medicine, Toxicology and Journal of Clinical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.